Polypeptide magnetic nanoparticle, preparation method therefor and use thereof
Described is a polypeptide magnetic nanoparticle having a specific targeting polypeptide and a magnetic nanoparticle. The amino acid sequence of the specific targeting polypeptide is VRRDAPRFSMQGLDA-X, and the C-terminal X thereof is a sequence of 5 to 20 amino acids. The amino acid in the amino acid sequence of C-terminal X is selected from one or more of: C, G, and N. The polypeptide magnetic nanoparticle can be used for CTC detection and molecular typing of various cancer types, including esophageal cancer, liver cancer, lung cancer, stomach cancer, bladder cancer, skin cancer, melanoma, breast cancer, colorectal cancer, cervical cancer, etc. Biomarkers of CTC molecular typing include PD-L1, HER2, ER, PR, AR, EGFR, VEGFR, CXCR4, etc. The polypeptide magnetic nanoparticle is helpful for CTC detection and the qualitative and semiquantitative analysis of expression levels of biomarkers at CTC level, thereby performing precise therapy such as targeted individualized targeted therapy or immunotherapy on patients.
1 . A magnetic nanoparticle comprising a specific targeting polypeptide, wherein the specific targeting polypeptide is a specific recognition polypeptide targeting an epithelial cell adhesion molecule, wherein the specific targeting polypeptide comprises an amino acid sequence as set forth in any one of SEQ ID NO:1-9.
2 . The magnetic nanoparticle comprising a specific targeting polypeptide according to claim 1 , wherein the magnetic nanoparticle further comprises streptavidin.
3 . A preparation method of the magnetic nanoparticle comprising a specific targeting polypeptide according to claim 1 , wherein the method comprises the following steps:
(1) preparing a polypeptide solution comprising the specific targeting polypeptide and a magnetic nanoparticle solution comprising the magnetic nanoparticle; and
(2) mixing and reacting the polypeptide and the magnetic nanoparticle solutions prepared in step (1) to obtain the magnetic nanoparticle comprising a specific targeting polypeptide.
4 . The method according to claim 3 , wherein in the step (1), a solvent for preparing the polypeptide solution is one or more selected from the following: water, physiological saline, PBS, HEPES; and/or a solvent for preparing the magnetic nanoparticle solution is one or more selected from the following: water, PBS, and HEPES.
5 . The method according to claim 3 , wherein in the step (1), a final concentration of the specific targeting polypeptide in the polypeptide solution is 1-1000 pg/mL; and/or a final concentration of the magnetic nanoparticle in the magnetic nanoparticle solution is 1-10000 pg/mL.
6 . The method according to claim 3 , wherein in the step (2), the mass ratio of the specific targeting polypeptide and the magnetic nanoparticle is 1:10-5:1.
7 . The magnetic nanoparticle comprising a specific targeting polypeptide according to claim 2 , wherein a particle size of the magnetic nanoparticle is 100-900 nm.
8 . The magnetic nanoparticle comprising a specific targeting polypeptide according to claim 1 , wherein the amino acid sequence is SEQ ID NO: 1.